Evidence map›Paper›PMID 36405590›Full record

ArticleFrontiers in medicine2022

Retroperitoneal alveolar rhabdomyosarcoma intruding into spinal canal: A case report and literature review.

Yongbai Zhang, Wenpeng Huang, Liming Li, Yongkang Qiu, Hao Jiao, Zhao Chen, Qi Yang, Lele Song, Lei Kang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yongbai ZhangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Liming LiDepartment of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yongkang QiuDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Hao JiaoDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Zhao ChenDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Qi YangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Lele SongDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Lei KangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, China.
Peking University · CNFirst Affiliated Hospital of Zhengzhou University · CNPeking University First Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rhabdomyosarcoma (RMS) is the most frequent soft sarcoma in children and adolescents. Alveolar rhabdomyosarcoma (ARMS) is a relatively rare subtype that is characterized by aggressive behavior and an unsatisfactory prognosis. An ARMS can arise anywhere but most commonly occurs at extremity sites with a very small fraction in the retroperitoneum. The utility of 2-Deoxy-2-[fluorine-18]-fluoro-D-glucose ( Case Report: A 3-year-old female child was accidentally found with a large left upper abdominal mass for a day. CT examination indicated a huge soft tissue mass in the left retroperitoneum extending superiorly to the level of the left hilus renalis and inferiorly to the left acetabulum in the pelvic cavity, with intrusion into the lumbar foramens. Conclusion: Retroperitoneal ARMS is rare and indicates a poor outcome with the potential to involve vital organs and intrude into the spinal canal. Accurate diagnosis and staging using PET/CT would contribute to better risk stratifications and appropriate treatment individually.

Indexed as

18F-FDGalveolar rhabdomyosarcomacase reportPET/CTretroperitoneumspinal canal intrusion

Identifiers

PMID36405590
PMCPMC9670135
OpenAlexW4308416688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.